サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：分子診断の世界市場（2022年）
市場調査レポート
商品コード
1127677

分子診断の世界市場（2022年）

Molecular Diagnostics Global Market Report 2022
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
分子診断の世界市場（2022年）
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

世界の分子診断の市場規模は、2021年の494億9,000万米ドルから2022年に496億4,000万米ドルに達し、CAGRで0.3％の成長が予測されています。また、2026年には477億8,000万米ドルに減少し、CAGRで-1.0％の成長が予測されています。感染症やさまざまな形態のがんの流行が、市場を牽引しています。

当レポートでは、世界の分子診断市場について調査分析し、市場の特徴、セグメント分析、地域分析、競合情勢などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 分子診断市場の特徴

第3章 分子診断の市場規模と成長

  • 世界の分子診断市場の実績（2016年～2021年）
    • 市場促進要因
    • 市場抑制要因
  • 世界の分子診断市場の予測（2021年～2026年）（2031年）
    • 市場促進要因
    • 市場抑制要因

第4章 分子診断市場セグメンテーション

  • 世界の分子診断市場：技術別、実績と予測
  • ポリメラーゼ連鎖反応（PCR）
  • DNAシーケンシング
  • 次世代シーケンシング
  • 世界の分子診断市場：製品別、実績と予測
  • 器具
  • 試薬・消耗品
  • ソフトウェア・サービス
  • 世界の分子診断市場：用途別、実績と予測
  • 腫瘍学
  • ファーマコゲノミクス
  • 感染症
  • 遺伝子検査
  • 神経疾患
  • 循環器疾患
  • 微生物学
  • その他
  • 世界の分子診断市場：エンドユーザー別、実績と予測
  • 病院
  • 研究所
  • その他（血液銀行、在宅医療機関、介護施設）

第5章 分子診断市場の地域別・国別分析

  • 世界の分子診断市場：地域別、実績と予測
  • 世界の分子診断市場：国別、実績と予測

第6章 アジア太平洋の分子診断市場

  • アジア太平洋の分子診断市場の概要
  • アジア太平洋の分子診断市場：技術別、実績と予測

第7章 中国の分子診断市場

  • 中国の分子診断市場の概要
  • 中国の分子診断市場：技術別、実績と予測

第8章 インドの分子診断市場

  • インドの分子診断市場の概要
  • インドの分子診断市場：技術別、実績と予測

第9章 日本の分子診断市場

  • 日本の分子診断市場の概要
  • 日本の分子診断市場：技術別、実績と予測

第10章 オーストラリアの分子診断市場

  • オーストラリアの分子診断市場：技術別、実績と予測

第11章 インドネシアの分子診断市場

  • インドネシアの分子診断市場：技術別、実績と予測

第12章 韓国の分子診断市場

  • 韓国の分子診断市場：技術別、実績と予測

第13章 西欧の分子診断市場

  • 西欧の分子診断市場の概要
  • 西欧の分子診断市場：技術別、実績と予測

第14章 英国の分子診断市場

  • 英国の分子診断市場の概要
  • 英国の分子診断市場：技術別、実績と予測

第15章 ドイツの分子診断市場

  • ドイツの分子診断市場：技術別、実績と予測

第16章 フランスの分子診断市場

  • フランスの分子診断市場：技術別、実績と予測

第17章 東欧の分子診断市場

  • 東欧の分子診断市場の概要
  • 東欧の分子診断市場：技術別、実績と予測

第18章 ロシアの分子診断市場

  • ロシアの分子診断市場：技術別、実績と予測

第19章 北米の分子診断市場

  • 北米の分子診断市場の概要
  • 北米の分子診断市場：技術別、実績と予測

第20章 米国の分子診断市場

  • 米国の分子診断市場の概要
  • 米国の分子診断市場：技術別、実績と予測

第21章 南米の分子診断市場

  • 南米の分子診断市場の概要
  • 南米の分子診断市場：技術別、実績と予測

第22章 ブラジルの分子診断市場

  • ブラジルの分子診断市場：技術別、実績と予測

第23章 中東の分子診断市場

  • 中東の分子診断市場の概要
  • 中東の分子診断市場：技術別、実績と予測

第24章 アフリカの分子診断市場

  • アフリカの分子診断市場の概要
  • アフリカの分子診断市場：技術別、実績と予測

第25章 分子診断市場の競合情勢と企業プロファイル

  • 分子診断市場の競合情勢
  • 分子診断市場の企業プロファイル
    • Becton
    • BioMerieux SA.
    • Danaher Corporation
    • Grifols
    • Hologic Inc.

第26章 分子診断市場における主な合併と買収

第27章 分子診断市場の動向と戦略

第28章 分子診断市場の将来の見通しと潜在的な分析

第29章 付録

目次
Product Code: h2524

“Molecular Diagnostics Global Market Report 2022 ” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global Molecular Diagnostics market.

This report focuses on Molecular Diagnostics market which is experiencing strong growth. The report gives a guide to the Molecular Diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the Molecular Diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Molecular Diagnostics global market report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider Molecular Diagnostics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The Molecular Diagnostics market section of the report gives context. It compares the Molecular Diagnostics market with other segments of the Molecular Diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, Molecular Diagnostics indicators comparison.

Scope

Markets Covered:

1) By Technology: Polymerase Chain Reaction (PCR), DNA Sequencing, Next-Generation Sequencing

2) By Product: Instruments, Reagents and Consumables, Software & Services

3) By Application: Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, Others

4) By End-User: Hospitals, Laboratories, Others (Blood Banks, Home Health Agencies, and Nursing Homes)

Companies Mentioned: Becton, BioMerieux SA., Danaher Corporation, Grifols, Hologic Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary

The major players in the molecular diagnostics market are: Becton, BioMerieux SA., Danaher Corporation, Grifols, Hologic Inc., Novartis AG, QIAGEN, Siemens Healthcare GmbH, Abbott, and Dickinson and Company.

The global molecular diagnostics market is expected to grow from $49.49 billion in 2021 to $49.64 billion in 2022 at a compound annual growth rate (CAGR) of 0.3%. The molecular diagnostics market is expected to decline to $47.78 billion in 2026 at a compound annual growth rate (CAGR) of -1.0%.

The molecular diagnostics market consists of sales of molecular diagnostics services and related products by entities (organizations, sole traders, partnership) that are utilised to direct patient management, from diagnosis to treatment, especially in the treatment of congenital anomalies, infectious diseases, and cancer. Molecular diagnostic is a term used to describe a class of techniques that are used to examine biological markers in the genetic code (genome) of an organism and to determine how their cells express their genes as proteins.

The main types of products of molecular diagnostics are instruments, reagents, consumables, software, and services. Instruments refer to a measuring device for determining the present value of a quantity under observation. The technologies include polymerase chain reaction (PCR), DNA sequencing, and next-generation sequencing and these are used in oncology, pharmacogenomics, infectious diseases, genetic testing, neurological disease, cardiovascular disease, microbiology, and other applications. The various end-users are hospitals, laboratories, and other end-users (blood banks, home health agencies, and nursing homes).

North America was the largest region in the molecular diagnostics market in 2021. The regions covered in molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The rising prevalence of infectious diseases and cancers of different forms drives the molecular diagnostics market. To determine whether mutations to a gene or chromosome may raise a person's chance of acquiring cancer or other disorders, molecular testing is employed. The increasing prevalence of infectious diseases and various types of cancer creates a demand for new diagnostic procedures including fast and specific molecular diagnostic tests. For instance, in 2020, according to National Cancer Institute, a US-based government agency, an estimated 1,806,590 new cases of cancer would be diagnosed in the United States and 606,520 people would die from the disease. Therefore, the increasing prevalence of cancer is driving the growth of the molecular diagnostic market.

The advances in genomics and proteomics are a key trend gaining popularity in the molecular diagnostics market. Polymerase chain reaction (PCR) is a recent development in genomics and helps in discovering new approaches to molecular diagnosis for disease diagnosis and pathogenesis of diseases. This enables better monitoring and a fast diagnosis and major organizations are investing to have a competitive edge. Following the trend, $600 million to support COVID-19 vaccine and therapy clinical trials led by the private sector, and for Canadian bio-manufacturing opportunities. This announcement was part of the $1 billion Plan to Mobilize Science. The growing research in proteomics and genomics will help develop more advanced molecular diagnostic techniques in the forecast period.

In April 2021, Hologic, a US-based women's health technology company, acquired Mobidiag Oy for an undisclosed amount. The acquisition would accelerate the global growth of Mobidiag's molecular diagnostic test platforms, which offer ease of use, multiplex capability, and rapid turnaround time. Mobidiag Oy is a Finland-based company that develops and provides molecular diagnostics for infectious diseases and antibiotic resistance.

The countries covered in the molecular diagnostics market are: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia."

Table of Contents

1. Executive Summary

2. Molecular Diagnostics Market Characteristics

3. Molecular Diagnostics Market Size And Growth

  • 3.1. Global Molecular Diagnostics Historic Market, 2016-2021, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Molecular Diagnostics Forecast Market, 2021-2026F, 2031F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Molecular Diagnostics Market Segmentation

  • 4.1. Global Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Polymerase Chain Rreaction (PCR)
  • DNA Sequencing
  • Next-Generation Sequencing
  • 4.2. Global Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Instruments
  • Reagents and Consumables
  • Software & Services
  • 4.3. Global Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oncology
  • Pharmacogenomics
  • Infectious Diseases
  • Genetic Testing
  • Neurological Disease
  • Cardiovascular Disease
  • Microbiology
  • Others
  • 4.4. Global Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals
  • Laboratories
  • Others (Blood Banks, Home Health Agencies, and Nursing Homes)

5. Molecular Diagnostics Market Regional And Country Analysis

  • 5.1. Global Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 5.2. Global Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

6. Asia-Pacific Molecular Diagnostics Market

  • 6.1. Asia-Pacific Molecular Diagnostics Market Overview
  • 6.2. Asia-Pacific Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7. China Molecular Diagnostics Market

  • 7.1. China Molecular Diagnostics Market Overview
  • 7.2. China Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

8. India Molecular Diagnostics Market

  • 8.1. India Molecular Diagnostics Market Overview
  • 8.2. India Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. Japan Molecular Diagnostics Market

  • 9.1. Japan Molecular Diagnostics Market Overview
  • 9.2. Japan Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

10. Australia Molecular Diagnostics Market

  • 10.1. Australia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Indonesia Molecular Diagnostics Market

  • 11.1. Indonesia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. South Korea Molecular Diagnostics Market

  • 12.1. South Korea Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Western Europe Molecular Diagnostics Market

  • 13.1. Western Europe Molecular Diagnostics Market Overview
  • 13.2. Western Europe Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. UK Molecular Diagnostics Market

  • 14.1. UK Molecular Diagnostics Market Overview
  • 14.2. UK Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Germany Molecular Diagnostics Market

  • 15.1. Germany Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. France Molecular Diagnostics Market

  • 16.3. France Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Eastern Europe Molecular Diagnostics Market

  • 17.1. Eastern Europe Molecular Diagnostics Market Overview
  • 17.2. Eastern Europe Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. Russia Molecular Diagnostics Market

  • 18.1. Russia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. North America Molecular Diagnostics Market

  • 19.1. North America Molecular Diagnostics Market Overview
  • 19.2. North America Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. USA Molecular Diagnostics Market

  • 20.1. USA Molecular Diagnostics Market Overview
  • 20.2. USA Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. South America Molecular Diagnostics Market

  • 21.1. South America Molecular Diagnostics Market Overview
  • 21.2. South America Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. Brazil Molecular Diagnostics Market

  • 22.1. Brazil Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. Middle East Molecular Diagnostics Market

  • 23.1. Middle East Molecular Diagnostics Market Overview
  • 23.2. Middle East Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Africa Molecular Diagnostics Market

  • 24.1. Africa Molecular Diagnostics Market Overview
  • 24.2. Africa Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 25.1. Molecular Diagnostics Market Competitive Landscape
  • 25.2. Molecular Diagnostics Market Company Profiles
    • 25.2.1. Becton
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. BioMerieux SA.
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Danaher Corporation
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Grifols
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Hologic Inc.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Molecular Diagnostics Market

27. Molecular Diagnostics Market Trends And Strategies

28. Molecular Diagnostics Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer